Press-release for stocks publishing date 2021 - 09

Prices are updated after-hours

Licensing Agreement for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.545 1.45% 7.6K

| -90.97% | O: -0.86% H: 1.33% C: 0.38%
license commercialization

Worldwide Licensing Agreement for CAL02 a Phase 2b/3, Novel First-in-Class Antitoxin Agent
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.545 1.45% 7.6K

| -90.97% | O: -0.86% H: 1.33% C: 0.38%
phase 2 phase 2b license

Eagle Pharmaceuticals Wins Vasopressin Patent Trial
Published: 2021-09-09 (Crawled : 19:00) - eagleus.com
EGRX | $4.545 1.45% 7.6K

| -90.97% | O: -0.86% H: 1.33% C: 0.38%
patent trial

79%

21%

AGBA | News | $1.22 205.0% 86M

EGOX | $0.0606 68.33% 250M

NVFY | $3.45 63.51% 20M

ZCMD | $1.98 36.55% 27M

CHRO | $1.66 35.51% 70K

INDO | $5.43 33.09% 10M

PAPL | $2.07 26.22% 550K

RWOD | $10.08 26.05% 5.6M

AULT | $0.304 25.57% 47M

HUSA 4 | $2.07 23.95% 2.1M

Save your searches and get alerts when important news are released.